The IFN I response in tumor cells is shaped by PARP7–p300/CBP interactions through distinct loss- and gain-of-function mechanisms
Preprint
Abstract
PARP7, a mono-ADP-ribosyl (MAR) transferase, is a key suppressor of the type I interferon (IFN-I) IFNβ in various tumor cells and a validated drug target. This negative regulation is reversed by small-molecule inhibitors of PARP7 catalytic activity, resulting in increased IFN-β expression. Yet, the mechanism of action of PARP7 inhibitors remains unclear because the relevant substrates of PARP7-mediated MARylation are unknown. Using an optimized analog- sensitive chemical genetic (ASCG) approach, we identified the co-activators, p300 and CBP, as nuclear PARP7 substrates. We identified an α-helical domain in PARP7 essential for p300/CBP interaction, MARylation, and proteasome degradation. Disrupting PARP7–p300/CBP interaction prevents PARP7’s suppression of IFNβ in colorectal cancer cells. p300/CBP reciprocally regulate PARP7’s activity and nuclear localization. Intriguingly, treatment with PARP7 inhibitors increased IFNβ expression more than PARP7 knockout in a p300/CBP-dependent manner. Our findings suggest that in some contexts, IFNβ induction by PARP7 inhibitors occurs via two mechanisms: inhibiting MARylation of p300/CBP (loss-of-function) and stabilizing the PARP7– p300/CBP complex (gain-of-function). Teaser: Chemical genetics discovery of p300 and CBP as substrates of PARP7 that are essential for PARP7-mediated regulation of IFNβ via a dual mechanism.Keywords
This publication has 87 references indexed in Scilit:
- A desthiobiotin labelled NAD+ analogue to uncover Poly(ADP‐ribose) polymerase 1 protein targetsChemBioChem, 2024
- Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatmentBiomedicine & Pharmacotherapy, 2024
- Immunomodulatory roles of PARPs: Shaping the tumor microenvironment, one ADP-ribose at a timeCurrent Opinion in Chemical Biology, 2023
- Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-β signalingCell Chemical Biology, 2022
- PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityCancer Cell, 2021
- Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signalingCell Chemical Biology, 2021
- Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research2018
- Phosphorylation of p300 increases its protein degradation to enhance the lung cancer progressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- Phosphorylation of p300 by ATM controls the stability of NBS1Biochemical and Biophysical Research Communications, 2010
- Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting ComplexCell, 2008